- Thursday, October 22, 2020
- IPC GENERAL
- COVID-19, IPC Partners, Other Orgs, Treatment
According to a new paper published by the team behind the PsoProtect registry, psoriasis patients treated with biologics are at a lower risk of being hospitalized due to COVID-19 than those treated with non-biologic systemic therapies.
Read the full article here: